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The health industry has always used natural products as a rich, promising, and alternative source of drugs that are used in the health
system. Propolis, a natural resinous product known for centuries, is a complex product obtained by honey bees from substances
collected from parts of different plants, buds, and exudates in different geographic areas. Propolis has been attracting scientific
attention since it has many biological and pharmacological properties, which are related to its chemical composition. Several in
vitro and in vivo studies have been performed to characterize and understand the diverse bioactivities of propolis and its isolated
compounds, as well as to evaluate and validate its potential. Yet, there is a lack of information concerning clinical effectiveness.The
goal of this review is to discuss the potential of propolis for the development of new drugs by presenting published data concerning
the chemical composition and the biological properties of this natural compound from different geographic origins.
1. Introduction
Over the years, nature is continually surprising with diver-
sified natural compounds that can be promising sources for
the discovery of new drugs important in medicine [1]. In
fact, approximately half of the currently available drugs were
obtained from natural compounds or related [2]. The use of
natural products as an essential route to new pharmaceutical
leads is continually growing and is a research field of enor-
mous interest because the different structural range of natural
compounds can provide lead compounds for therapeutic
improvement based on rationalized molecular modifications
[3, 4]. It is well known that scientists have curiosity in herbs
and other natural plant products for research; however only
in the last years the interest in modified plant products
by animals, which normally have been largely ignored and
wasted, has been increased [5, 6].
Propolis, a complex mixture of compounds also called
bee glue, is a natural resinous product that honeybees collect
from several plants and mix it with beeswax and salivary
enzymes (𝛽-glucosidase) [7–11]. As inferred for the meaning
of the Greek word propolis—pro-, for or in defence, and
polis, the city [10]—bees use propolis on their hives as
protection against predators and microorganisms, to repair
damage, as a thermal isolator, and to build aseptic locals
to prevent microbial infection of larvae [7, 9, 10, 12]. Since
ancient times, propolis has been used by humans to meet
the needs of health and food preservation [5]; but only in
the last years the interest in this complex natural product
has increased due to its broad spectrum of biological and
pharmacological properties [12–14]. Propolis is a lipophilic
material that is hard and breakable when cold but soft,
flexible, and very sticky when warm; it possesses an enjoyable
aromatic smell and different coloration, including brown,
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green, and red, among others [5, 7, 12]. In terms of chemical
composition, it is generally composed of 50% resin, 30%
wax, 10% essential oils, 5% pollen, and 5% other substances
which includeminerals and organic compounds like phenolic
acids (cinnamic and caffeic acid) or their esters, flavonoids
(flavones, flavanones, flavonols, and dihydroflavonols chal-
cones), terpenes, aromatic aldehydes and alcohols, fatty acids,
stilbenes, and 𝛽-steroids [8, 9]. Analysis of different samples
revealed that propolis chemical composition is difficult to
standardize because it depends on different phytogeographic
characteristics like vegetation, season, and environmental
conditions of the site of collection, as bees select different
plants in different habitats for propolis production [6, 8, 9].
Several in vitro and in vivo studies have been describing
the plethora of biological activities and chemical profiles
of propolis from different geographic origins. This review
highlights published data about such works focusing on the
antimicrobial, anti-inflammatory, antioxidant, immunomod-
ulatory, and antitumor activities of different propolis types, in
order to unravel the potential of this natural compound for
the development of new drugs.
2. Use of Propolis in Ancient
and Current Times
Propolis is not a new discovery. Since bee’s domestication,
men explore its products to their own benefit and propolis,
one of the most important chemical weapons of bees, is no
exception, having been employed extensively since almost
immemorial times [6, 13, 15–17]. It is stated that propolis use
dates back to ancient times, at least to 300 BC, where it was
used in folk medicine and other activities in many parts of
the world [16]. It was familiar to the Egyptians, in particular
by the priests who controlled medicine and chemistry and
knew very well propolis antiputrefactive properties. They
learned from the bees the embalming capacity of propolis as
this natural product is used to perform the mummification
of corpses and prevent spread of infections. The Greek
and the Roman physicians also acknowledged the potential
of propolis by employing it in wound treatment, as an
antiseptic and cicatrizing agent, and as mouth disinfectant.
The Persians described propolis as a drug capable of acting
against eczemas, myalgia, and rheumatism. Populations of
the new world, like Incas, also used propolis as an antipyretic
agent.
Between the 17th and 20th century, this natural product
became very popular in Europe. In 1969, in the former Union
of Soviet Socialist Republics (USSR), the use of propolis was
accepted in human and veterinary medicine, with several
applications including the treatment of tuberculosis, where
the regression of lung problems and recovery of appetite
were observed. Also, it was believed to cure some diseases in
folk Georgian medicine. During World War II (1939–1945),
doctors used propolis to treat wounds [15–17], but only in
1985, in Japan, propolis was considered as very promising in
pharmacology. Before that, propolis was considered a prod-
uct without market value, especially because its production
is low and affects honey production. Nowadays, propolis
is an important product in alternative medicine in Japan,
being widely imported from Brazil [18]. In the 17th century,
the Italian Antonio Stradivari who is considered the most
significant and the greatest crafter of string instruments, like
violins, used propolis as an ingredient in the varnish of his
instruments. Curiously, such as in the 17th century, propolis
is currently used in rosin for stringed instruments and in the
repair of accordions [16].
Propolis is one of the few natural products that main-
tained popularity for a long time, although it is not considered
a therapeutic agent in conventional medicine. Actually, it is
widely used as a component in pharmaceutical and cosmetic
products such as antiacne creams, facial and body creams,
ointments and lotions, and several formulations for oral
hygiene [15, 16]. It is also used in some foods and beverages,
or simply as food supplement or healthy drinks. This name
was attributed to the drinks because it is thought that propolis
improves human health and prevents diseases such as heart
disease or diabetes, among others [19].
3. Origin and Composition of Propolis
Propolis knowledge has registered an important evolution
over time, due to exhaustive studies regarding its chem-
ical composition and biological activities. In the 60s, it
was thought that, despite its complexity, propolis chemical
composition was more or less constant. Nevertheless, in
the following years, analysis of a large number of samples
from different geographic origins revealed that chemical
composition of propolis is highly variable and also difficult
to standardize because it depends on factors such as the
vegetation, season, and environmental conditions of the site
of collection [6, 8, 9]. Marcucci [7] and Bankova et al. [10]
registered more than 300 substances in propolis and recent
reports showed the presence of compounds never mentioned
before [12, 17, 20, 21].
Generally, the main constituents of propolis are resin and
volatiles, which are substances obtained from a variety of
botanical processes in different parts of plants, and beeswax,
secreted by the bees [9]. Typical compounds are summarized
in Table 1. As can be seen, plant sources vary among the
different parts of the globe, leading to panoply of compounds.
In a review on propolis standardization, different resin types
were proposed: poplar propolis, birch, green, red, “Pacific,”
and “Canarian” [9, 12]. Samples of poplar propolis (e.g.,
from Europe, North America, New Zealand, and temperate
zones of Asia) are mainly composed of flavonoids, phenolic
acids, and their esters [10, 20, 22], clearly different from
other propolis types (Table 1). Portuguese propolis, despite
similar to the ones found in European samples, also contains
new methylated, esterified, and hydroxylated derivatives of
flavonoids and pinocembrin/pinobanksin derivatives con-
taining a phenylpropanoic acid derivative moiety in their
structure [20, 21]. Our group recently showed that propolis
from Pereiro (district of Guarda, Beira Alta) (Figure 1) has a
high concentration of phenolic components [23].
Poplar-type propolis is undoubtedly themost studied one
but there are many other propolis types. Recent studies have
revealed a new type of European propolis: Mediterranean
propolis. This type of propolis is distinguished by the high
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Figure 1: Crude sample of propolis from Pereiro, obtained in the
central region of Portugal (Guarda).The sample was kindly supplied
by Engineer Pedro Fernandes (Mel do Abel).
concentration of diterpenoids and is found in many regions
like Greece [24, 25], Switzerland [26],Malta [27], Turkey [28–
30], or Algeria [28, 31].
Propolis from tropic regions, like Brazil, Cuba,Venezuela,
and Chile, has been attracting much attention in the
last years due to its particular chemical profiles. Preny-
lated phenylpropanoids, prenylated p-coumaric acids, ace-
tophenones, diterpenic acids, and caffeoylquinic acids were
shown to be very common and abundant in propolis from
Brazil, mainly from the south-eastern region [9, 10, 21].
The flavonoids kaempferide and isosakuranetin and some
amounts of kaempferol were also found in Brazilian samples
[32]. Additionally, red propolis from the northeast regions
of Brazil presents high concentrations of phenolic acids and
the flavonoids formononetin, isoliquiritigenin, liquiritigenin,
medicarpin, and biochanin A [33–35]. Cuban propolis has
a peculiar enrichment in polyisoprenylated benzophenones,
more specifically nemorosone, and a minor content of a
mixture of xanthochymol and guttiferone E [9, 36] making
this type of sample chemically distinct from both European
and Brazilian propolis. Propolis from Venezuela is also
composed of polyisoprenylated benzophenones in addition
to the usual constituents found in samples of tropical regions
[9, 37, 38].
Information about the chemical composition of Aus-
tralian propolis is very limited despite the great biodiversity
of the island. Propolis from Kangaroo Island is mainly
composed of stilbenes, some of them being prenylated. Ad-
ditionally, it has also some prenylated cinnamic acids and
flavonoids [39], like 2󸀠,3󸀠,4󸀠-trimethoxychalcone, 2󸀠-hy-
droxy-3󸀠,4󸀠-dimethoxychalcone, 2󸀠,4󸀠-dihydroxy-3󸀠-metho-
xychalcone, 5,7-dihydroxy-2,3-dihydroflavonol 3-acetate (pi-
nobanksin 3-acetate), and 5,7-dihydroxy-6-methoxy-2,3-
dihydroflavonol 3-acetate [40]. Western Australian propolis
is composed of Xanthorrhoeol, pterostilbene, sakuranetin,
and pinostrobin [41]. Propolis of Australian stingless bees
(Tetragonula carbonaria) is composed of C-methylated
flavanones [42].
“Pacific” propolis (e.g., Okinawa, Taiwan, Hawaii, Indo-
nesia, and Myanmar) is another particular type of propolis.
A new family of compounds, the prenylflavonoids, more
specifically isonymphaeol-B, was identified in Okinawa
propolis although three already known compounds—nym-
phaeol-A, nymphaeol-B, and nymphaeol-C—have also
been isolated in three samples [43]. As Okinawan propolis,
Hawaiian propolis is also composed of nine prenylflavonoids
[44]. Taiwanese propolis is composed of eight prenylfla-
vanones, nymphaeol-A, nymphaeol-B, and nymphaeol-C,
propolins A, B, and E, isonymphaeol B, and 3󸀠-geranyl-
naringenin [45]. In another sample of the Pacific region,
the Indonesian propolis, an inseparable mixture of four
alk(en)ylresorcinols (5-pentadecylresorcinol, 5-(8󸀠Z,11󸀠Z-
heptadecadienyl)-resorcinol, 5-(11󸀠Z-heptadecenyl)-resor-
cinol, and 5-heptadecylresorcinol), along with four prenylfla-
vanones, propolins D, C, F, and G, and three cycloartane-
type triterpenes, mangiferolic acid, isomangiferolic acid,
and 27-hydroxyisomangiferolic acid, was identified [46].
Additionally, fractioning of propolis extracts from Myanmar
led to the isolation of two new cycloartane-type triterpenes,
together with 13 cycloartanes and four known prenylated
flavanones [47]. Thailand propolis, which might be
possibly obtained from Styrax trees, comprises not only
the typical compounds of temperate regions but also the
two new phenylallylflavanones (7󸀠󸀠S)-8-[1-(4󸀠-hydroxy-3󸀠-
methoxyphenyl)prop-2-en-1-yl]-(2S)-pinocembrin and (E)-
cinnamyl-(E)-cinnamylidenate [48]. In propolis fromCanary
Islands, a different phenolic profile was found, furofuran
lignans being the main compounds. Six furofuran lignans
were isolated and characterized as sesamin, episesamin,
methyl xanthoxylol, aschantin, sesartenin, and yangambin.
Propolis also contains sugars and sugar alcohols [10, 49].
Many studies with African propolis from different regions,
like Kenya, Cameroon, Congo, Oman, and Ethiopia, showed
that triterpenoids are major chemical components [50–53].
Southern Nigeria propolis is uncommon since it presents
prenylated isoflavonoids, like Brazilian red propolis, and a
high abundance of stilbenoid compounds [54].
Propolis additionally contains minerals such as mag-
nesium, calcium, iodine, potassium, sodium, copper, zinc,
manganese, and iron; some vitamins like B1, B2, B6, C,
E, and D, as well as provitamin A; a few fatty acids; and
also some enzymes derived from bee glandular secretion or
possibly from pollen like succinic dehydrogenase, adenosine
triphosphatase, glucose-6-phosphatase, acid phosphatase,
𝛼-amylase, 𝛽-amylase, 𝛼-lactamase, 𝛽-lactamase, maltase,
esterase, and transhydrogenase [17, 55]. Polysaccharides like
starch and the di- and monosaccharaides glucose, fructose,
ribose, rhamnose, talose, gulose, and saccharose are com-
monly present in propolis too [55].
4. Biological Properties and Therapeutic
Activity of Propolis
Despite propolis popularity over time, it is not consid-
ered as a therapeutic agent in conventional medicine as
the standardization of chemical composition and biological
activity is lacking. Such standardization is indispensable
for acceptance in the health system. Thus, characterization
of different types of propolis according to its plant origin
and corresponding chemical profile is mandatory. Studies
about propolis bioactivity must start with chemical profiling
of the extracts since that information is essential to have
detailed and consistent comparative data between each type
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of biological activity and chemical data. This information
allows extrapolating the possible activity and mechanism of
action of new propolis under study and provides substantial
clues for the development of new drug candidates [6, 9].
In the last decades, several studies have demonstrated the
biological and pharmacological actions of different world-
wide propolis samples.The following sections summarize the
recent published information about antibacterial and anti-
fungal [6, 7, 56–59], antiviral [7, 59, 60], anti-inflammatory
[61], antioxidant [62–64], immunomodulatory [6, 65, 66],
and antitumor activities [8, 17, 23, 64, 66, 67], revealing the
interest of researchers in this bee product and its potential
for the development of new drugs as well.
4.1. Antioxidant Activity. It is well known that an endogenous
stimuli, like cellular metabolism, and exogenous agents like
UV, toxins, and drugs, among others, generate reactive






−), and hydroxyl ion (HO−), as well as
reactive nitrogen species (RNS), especially nitric oxide (NO).
Carbohydrates, proteins, lipids, and nucleic acids, among
other biomolecules, when exposed to the reactive species,
suffer oxidative modifications that modify the cell and lead
to its death [68–70]. Oxidative stress is responsible for the
occurrence of a wide variety of human diseases, such as
neurodegenerative [71] or cardiovascular diseases [72, 73],
cancer [68, 74], diabetes [6], and atherosclerosis [75].
In the last years, several studies have been performed
to evaluate the antioxidant capacity of natural products.
Propolis extracts, composed of different polyphenols, have
been reported to possess a potent antioxidant activity [70,
76, 77]. Additionally, the chemical varieties in different
propolis samples from different regions have an influence
on the antioxidant activity. Recently, Fabris et al. showed
that a sample of Italian and Russian propolis ethanol extract
(PEE), which have a similar polyphenolic composition, have
a similar antioxidant activity, while Brazilian PEE, which
have low polyphenolic composition, have a weak antioxidant
activity [78]. Another study also showed, using different
samples of Transylvania PEE, a positive correlation between
high polyphenolic composition and high antioxidant activity
[79]. Phenolic acids and flavonoids are characterized by
a powerful antioxidant activity, which is closely related to
the chemical structure of the compounds [80]. Briefly, the
antioxidant activity is exerted by inhibiting the activity of
some enzymes (e.g., xanthine oxidase, protein kinase C,
ascorbic acid oxidase, cyclooxygenase, lipoxygenase, Na+/K+
ATPase, and cAMP phosphodiesterase) which inhibit the
production of ROS species; by scavenging, interrupting the
reactions that lead to the lipid peroxidation; by chelating
metal ions, mainly iron and copper, that are involved in the
process of free radical creation; or by potentiating the action
of other antioxidants [55]. Table 2 summarizes some of the
studies addressing the antioxidant activity of propolis.
Moreira et al. [62] and Miguel et al. [63] proposed that
Portuguese propolis, an important source of total phenols,
flavones, and flavonols, could be beneficial for human health
due to its antioxidant properties. Portuguese propolis also
protects human erythrocytes from free radicals damaging
by decreasing lipid peroxidation [64]. These studies suggest
that Portuguese propolis is a powerful antioxidant agent
that can be used against oxidative stress, thus maintaining
the structural and functional integrity of the cells. Cuesta-
Rubio et al. [36] demonstrated that nemorosone, the most
abundant polyisoprenylated benzophenone present in Cuban
propolis, exhibits antioxidant capacity. However, when this
compound suffers methylation, a process that facilitates the
separation of the compound from the propolis sample, the
antioxidant property is abolished. Ethyl acetate extract of
Kangaroo Island propolis, which is rich in stilbenes, showed
a stronger scavenging activity [39]. Yang et al. showed that
ethyl acetate of propolis collected in Anhui, China, has
strong scavenging activity and ferric reducing activity, those
activities being influenced by caffeic acid, phenethyl caffeate,
cinnamyl caffeate, and benzyl caffeate [81]. Another study
showed that samples of methanolic extracts of Algerian
propolis that contains high amounts of caffeic acid esters
and flavanones, kaempferol, and galangin possess strong
scavenging activity and ferric reducing activity [31]. Uruguay
propolis with high polyphenolic composition inhibits low-
density lipoprotein (LDL) peroxidation and protein nitra-
tion in vitro. Moreover, it induces the expression of nitric
oxide synthase (eNOS) and inhibits NADPH oxidase in
bovine aortic endothelial cells [82]. In another study, the
topical administration of Romanian PEE in mouse, either
prior to or after UVB exposure, significantly attenuated the
malondialdehyde (MDA) formation and restored glutathione
peroxidase (GSH-Px) activity [83]. Talas et al. [84] showed
that Turkish PEE has antioxidant properties in the liver
tissue of NOS inhibited rats. In fact, NOS inhibition caused
an increase in CAT activity and MDA levels, effect that
was significantly decreased when the rats were treated with
PEE. It is well known that propolis composition is variable;
nevertheless, one of itsmajor components, CAPE (caffeic acid
phenethyl ester), plays an important role in the antioxidant
activity [85–87].
Antioxidant activity is one of the most studied and
important activities of propolis, though there are no studies
with data on the safe dose to be used in humans.Thus, clinical
studies using propolis and its active compounds are needed.
4.2. Anti-Inflammatory Activity. Inflammation is an event
that normally occurs in response to the constant exposure
to environmental and endogenous stimuli as well as to
accidental damage [61]. A complex cascade of chemical
signals initiates after tissue injury and maintains a host
response to repair the injured tissue. There are two stages
of inflammation: acute and chronic. Acute inflammation is
mediated through the activation of the immune system cells,
which migrate to the site of damage and release growth
factors, cytokines, and ROS/RNS species. Chronic inflamma-
tion occurs when the acute inflammation is not successfully
resolved. This inflammatory condition plays a critical role in
the pathogenesis of many diseases including atherosclerosis,
cancer, asthma, Alzheimer’s, and Parkinsonism [88, 89].
Several studies have associated different types of propolis
and its various constituents with anti-inflammatory activ-
ity [61, 90–95]. Table 3 summarizes the anti-inflammatory





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8 Evidence-Based Complementary and Alternative Medicine
mechanisms investigated with propolis and its chemical
constituents. Recently, the role of the flavonoids quercetin,
flavonols, and flavones in modulating inflammatory cell
function was studied [92]. Funakoshi-Tago et al. [96] inves-
tigated the anti-inflammatory effects of flavonoids isolated
from Nepalese PEE on the IL-33 signaling pathway. The
isolated flavonoids 3󸀠,4󸀠-dihydroxy-4-methoxydalbergione,
4-methoxydalbergion, cearoin, and chrysin inhibited the
expression of inflammatory genes including IL-6, TNF-𝛼,
and IL-13 in bone marrow-derived mast cells (BMMC) and
also inhibited the activation of IKK, which leads to the
degradation of I𝜅B𝛼 and inhibits the activation of nuclear
factor 𝜅B (NF-𝜅B).
The release and oxygenation of arachidonic acid are a
critical event in inflammation. Mirzoeva and Calder [90]
demonstrated that propolis components such as CAPE, caf-
feic acid, quercetin, andnaringenin, among others, inhibit the
production of eicosanoids. In fact, these components signif-
icantly suppressed the lipoxygenase pathway of arachidonic
acid metabolism, CAPE being the most potent modulator.
Another study indicated that CAPE treatment improves
hepatic steatosis induced by high-fat diet in a mouse model.
This effect was attributed to the reduction of c-Jun-N-
terminal kinase (JNK1/2) andNF-𝜅B activationwith decrease
in COX-2 expression [97]. Recently, it was reported that
CAPE exhibits inhibitory effects on the production of proin-
flammatory cytokines (interleukin-1𝛽 (IL-1𝛽)), tumor necro-
sis factor-𝛼 (TNF-𝛼), and monocyte chemoattractant pro-
tein 1 (MCP-1) from lipopolysaccharide- (LPS-) stimulated
RAW264.7 macrophages [98]. Machado et al. [99] showed
that Brazilian green propolis water extracts (PWE) modulate
an anti-inflammatory cellular response in the model of LPS-
induced pulmonary inflammation by decreasing the number
of macrophages and neutrophils. Additionally, it induced a
reduction in the secretion of IL-6 and TNF-𝛼 and an increase
in TGF-𝛽 and IL-10. Another study showed that Brazilian
red PEE promotes a significant decrease in renal macrophage
infiltration in rats with chronic kidney disease [100]. Bu´falo
et al. [101] demonstrated that Brazilian PEE and caffeic
acid inhibited LPS-induced NO production by RAW264.7
macrophages, acting at the transcriptional level and sug-
gesting that their anti-inflammatory effects were mediated
by downregulating NF-𝜅B, p38 MAP kinase, and JNK1/2.
According to Naito et al. [95], topical application of Brazilian
PEE is effective in inhibiting carrageenan-induced rat hind
paw edema.This sample appears to inhibit the chemotaxis of
human polymorphonuclear leukocytes (PMNs), which also
contributes to its anti-inflammatory effects. Another study
showed the topical anti-inflammatory activity of propolis
from Chile in mice ear with induced-edema. In fact, PEE
from Buin, Chile, was the most active against the inflamma-
tion induced by 12-O-tetradeca-noylphorbol-13-acetate and
arachidonic acid and also inhibits significantly NO release
by the macrophages [102]. More recently, Boudreau et al.
[103] indicated that CAPE is a potent leukotriene biosynthesis
inhibitor in PMNs that blocks 5-lipoxygenase (5-LO) activity
and arachidonic acid release. A Croatian PEE may improve
psoriatic-like skin lesions, whichwere induced in the study by
irritant agents like n-hexyl salicylate or di-n-propyl disulfide,
by reducing the lipid peroxidation in the skin and total
number of inflammatory cells in the skin and peritoneal
cavity, more specially by suppressing functional activity of
macrophages [104].
4.3. Immunomodulatory Activity. Natural substances are
considered alternative adjuvant therapies in the treatment of
different diseases due to their immunomodulatory effects.
Information about this type of activity was scarce for propolis
until the 1990s; but published work in the last years has pro-
vided information about the influence of different propolis
samples on the immune system [65, 105–112] (Table 4).
In a study using Brazilian green propolis, it was seen
that the administration for 3 days of a PEE to male BALB/c
mice modulated the activation of the initial steps of the
immune response by upregulating toll-like receptor- (TLR-)
2 and toll-like receptor-4 expression and proinflammatory
cytokines (IL-1 and IL-6) production by macrophages and
spleen cells [105]. Another study demonstrated that Brazilian
greenPEEupregulates TLR-4 andCD80 expression in human
monocytes as well as TNF-𝛼 and IL-10 production [113]. It
was also shown that caffeic acid stimulates the activity of
monocytes againstC. albicans but it inhibits TLR-2 andHLA-
DR expression as well as TNF-𝛼 and IL-10 production [114].
Additionally, Missima et al. [115] showed that Brazilian
green PEE administered to stressed mice reduces the proin-
flammatory cytokines IL-1𝛽 and IL-6. When administered to
melanoma-bearing mice submitted or not to chronic stress,
it induces high levels of IL-1𝛽 and IL-6 and also stimu-
lates Th1 cytokines production, indicating the activation of
antitumour cell-mediated immunity. Bachiega et al. [116]
investigated the immunomodulatory effect of propolis and
cinnamic and coumaric acids on cytokines IL-1𝛽, IL-6, and
IL-10 production. Peritonealmacrophages fromBALB/cmice
were incubated with different concentrations of propolis
(5, 50, and 100mg/well) and coumaric and cinnamic acid
(50 and 100mg/well). Propolis and the acids stimulated IL-
1𝛽 production and significantly inhibited IL-6 production.
Then, after LPS incubation, the inhibitory concentrations of
cinnamic and coumaric acids prevented efficiently its effects
on IL-6 production, whereas propolis inhibited LPS effects
both before and after its addition. Additionally, propolis and
coumaric and cinnamic acids inhibited IL-10 production. A
study which evaluated the effect of Brazilian green propolis









generation and decreased NO generation, which favours
the microbicidal activity. Recently, the immunomodulatory
effect of propolis collected in Brazil was evaluated in Leish-
mania (Viannia) braziliensis experimental infection. Data
shows that macrophages incubated with propolis showed a
significant increase in interiorization and further killing of
parasites. Also, an increased TNF-𝛼 production was seen in
propolis-pretreated mice, whereas IL-12 was downregulated
during the infection [117].
The immunomodulatory action of propolis does not
occur only at the macrophage level. In fact, some studies
show that this action has also an effect on lymphocyte pro-
liferation [106, 108]. Sa´-Nunes et al. [108] showed inhibitory









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































10 Evidence-Based Complementary and Alternative Medicine
effects of Brazilian green propolis on splenocyte proliferation,
effect that was attributed to flavonoids, and enhancement
effects on interferon- (IFN-) 𝛾 production by spleen cells.
CAPE displays inhibitory effects on transcription factors NF-
𝜅B and NFAT and, as a consequence, inhibits IL-2 gene
transcription, IL-2 receptor expression, and proliferation of
human T cells [94]. This provides new information into the
molecular mechanisms involved in the anti-inflammatory
and immunomodulatory activities of propolis. CAPE has
various biological activities but its effect on the immunomod-
ulatory activity remains little studied. According to Wang
et al. [112], CAPE can be useful in the treatment of asthma
and other allergic diseases because it can inhibit cytokines
and chemokines production by human monocyte-derived
dendritic cells (MoDCs), which might be related to the
NF-𝜅B signalling pathway. Another study demonstrated for
the first time that Brazilian propolis significantly inhibited
the generation of Th1 cells. Furthermore, the effects of
propolis were investigated on 2,4,6-trinitrobenzene sulfonic
acid- (TNBS-) induced colitis in a mouse model. Propolis
reduced the frequency of IFN-𝛾-producing CD4 T cells
in a dose-dependent way under Th1-polarizing conditions.
The inhibitory effect of propolis on Th1 differentiation was
demonstrated in vivo too, and the severity of colitis in
propolis-fed mice was significantly lower than that of mice
fed with the control diet [118].
4.4. Antiviral Activity. Propolis comprises a complexity of
compounds which play a role in antiviral protection. Despite
the few data available regarding this activity, it was shown that
propolis from different geographic regions has considerable
antiviral activity by acting at different levels and interfering
with the replication of some viruses [12], like herpes simplex
types 1 and 2, adenovirus type 2, influenza virus, or human
immunodeficiency virus (HIV), among others [7, 60, 119–
124]. Table 5 summarizes the antiviral activity of propolis and
its chemical constituents.
Schnitzler et al. [123] analysed the antiviral effect of
PWE and PEE from Czech Republic as well as that of
the constituents caffeic acid, p-coumaric acid, benzoic acid,
galangin, pinocembrin, and chrysin, against herpes simplex
virus type 1 (HSV-1) in cell culture. Both extracts exhibited
high anti-HSV-1 activity when cells were treated prior to
viral infection, galangin and chrysin being the main bioac-
tive compounds. Amoros et al. [60] showed the antiviral
activity of the major flavonoids of propolis, more specifically
flavonols and flavones, the first being more active against
HSV-1. Additionally, they analysed the effect of propolis on
several DNA and RNA viruses (HSV-1, HSV-2, adenovirus
type 2, vesicular stomatitis virus (VSV), and poliovirus type
2). Propolis at a concentration of 30𝜇g/mL reduced the
titer of herpes virus; however, vesicular stomatitis virus
and adenovirus were less susceptible. In addition, propo-
lis appears to exert a virucidal action on the enveloped
viruses HSV and VSV [120]. Recently, it was shown that
hydromethanolic extract of geopropolis from the stingless
bee Scaptotrigona postica (Brazil) inhibits theHSV replication
and also the entry of the virus into cells, effect that was
attributed to the C-glycosyl flavones, catechin-3-O-gallate,
and 3,4-dicaffeoylquinic acid [125]. According to Tait et
al. [126], natural and synthetic flavonoids might interfere
with picornavirus replication preventing the decapsidation
of viral particles and RNA release within cells or blocking
viral RNA synthesis. These authors also showed that differ-
ent homoisoflavonoids have good antiviral activity against
the coxsackie viruses B3, B4, and A9 and echovirus 30.
Shvarzbeyn and Huleihel [127] tried to determine which
step of Tax oncoprotein-induced NF-𝜅B activation is blocked
by propolis and CAPE and showed that both substantially
inhibited the activation of NF-𝜅B-dependent promoter by
Tax. Also, they strongly prevented both Tax binding to I𝜅B𝛼
and its induced degradation by Tax. Ma et al. [128] showed
that nanometer propolis flavones could significantly inhibit
in vitro porcine parvovirus (PPV) infecting PK-15 cells and
in vivo they restrain the PPV copy in lung, gonad, and blood,
decrease the impact of PPV on weight of guinea pigs, and
increase hemagglutination inhibition of PPV in serum as well
as improving the contents of IL-2, IL-6, and 𝛾-IFN.
Over recent years, therapeutic benefits of propolis and/or
its isolated compounds have been described in HIV treat-
ment. Ito et al. [129] tested the anti-HIV activity in H9
lymphocytes of triterpenoids melliferone, moronic acid,
anwuweizonic acid, and betulonic acid and four known
aromatic compounds isolated from Brazilian propolis and
showed that moronic acid had significant anti-HIV activity.
Gekker et al. [119] assessed the anti-HIV-1 activity of propolis
in CD4+ lymphocytes and microglial cell cultures, observ-
ing the inhibition of viral expression in a concentration-
dependent way.The possible mechanism of propolis antiviral
property was suggested to involve inhibition of viral entry.
4.5. Antimicrobial Activity. Antimicrobial activity, one of
the most studied propolis biological properties, is very well
documented. This bioactivity has been largely investigated
in the last years due to the need of new treatments against
infectious diseases, especially with the increase of resistant
pathogens to current antibiotics. Tables 6 and 7 summarise
the antibacterial and antifungal activities found in propolis
from different geographic origin and/or its chemical con-
stituents.
4.5.1. Antibacterial Activity. Propolis effect against several
bacterial strains has evaluated [7, 56–59, 130] and supported
the fact that propolis is more active against Gram-positive
bacteria than Gram-negative bacteria [12, 59]. Briefly, data
from different studies showed that propolis inhibits bac-
terial motility and enzyme activity, exhibits bacteriostatic
activity against different bacterial genera, can be bactericidal
in high concentrations, and affects cytoplasmic membrane
[130].
Mirzoeva et al. [130] investigated the effect of PEE
on the physiology of Bacillus subtilis, Escherichia coli, and
Rhodobacter sphaeroides, proposing that propolis and some
of its components, like cinnamic acid and flavonoids, affect
the ion permeability of the inner bacterial membrane causing
the dissipation of the membrane potential and inhibiting
bacterial motility. A recent study [131] provided valuable
information for understanding the potential anti-H. pylori













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































16 Evidence-Based Complementary and Alternative Medicine
mechanism of CAPE. H. pylori, a major factor for gas-
trointestinal illnesses, contains the enzyme H. pylori peptide
deformylase that catalyses the removal of formyl group from
the N-terminus of nascent polypeptide chains. Since the
action of this enzyme is essential for H. pylori survival, it is
considered a promising therapeutic drug target. Results from
absorption spectra and crystal structural characterization
showed that CAPE is a competitive inhibitor of peptide
deformylase, blocking the substrate entrance and preventing
substrate from approaching the active site [131].
It has been suggested that the combination of propolis
with other antibiotics would allow dose reduction of selected
antibiotics, thus potentiating their effect. The antibacterial
activity of Italian PEE in some clinically isolated Gram-
positive strains, as well as the synergetic effect with some
antibiotics, was assessed by Scazzocchio et al. [56]. Ital-
ian PEE drastically increased the effect of ampicillin, gen-
tamycin, and streptomycin and moderated the action of
chloramphenicol, ceftriaxone, and vancomycin. No effect
was observed when used simultaneously with erythromycin.
Wojtyczka et al. [132] evaluated the in vitro antimicrobial
activity of a Polish PEE against methicillin-sensitive S. aureus
(MSSA) and methicillin-resistant S. aureus (MRSA) clinical
isolates and also the combined effect of propolis with ten
selected antistaphylococcal drugs. PEE displayed varying
effectiveness against twelve S. aureus strains and potentiated
the antimicrobial effect of eight antistaphylococcal against
all tested strains. No synergism was observed in the case
of ciprofloxacin and chloramphenicol. In another study, the
effect of dichloromethane extract of French propolis against
different human pathogenic bacterial strains was also tested.
Although Gram-negative bacteria were not susceptible to
the extract, a significant antibacterial activity against both
methicillin-resistant and methicillin-susceptible S. aureus
strains was observed [133]. The same was confirmed by
Velikova et al. [28] using different PEE from Bulgaria,
Greece, Turkey, and Algeria. All the samples showed a
good antibacterial activity against S. aureus but a week or
lacking effect against E. coli. Australian PEE from stingless
bee Tetragonula carbonaria also inhibited the growth of S.
aureus. Nevertheless, it was less active against P. aeruginosa
[42]. The same was observed by Papachroni et al. [53]
using PEE from Cameroon and Congo.Contrary to these
studies, Katirciog˘lu and Mercan [134] showed that Turkish
PEE was effective against Gram-negative bacteria like E. coli.
Orsi et al. [135] investigated the possible synergism between
Brazilian and Bulgarian propolis and antibiotics acting on
DNA (ciprofloxacin and norfloxacin) and on metabolism
(cotrimoxazole) in Salmonella typhi. Both samples had
antibacterial activity, but no synergistic effect was detected.
Recently, the suitability of nanohydroxyapatite- (nano-
HA-) based surfaces containing two Brazilian PEE (green
and red ones) to prevent S. aureus bacterial growth and
biofilm was studied. The nanoHA impregnated with the
two highest concentrations (12 and 25𝜇g/mL) of red PEE
showed a remarkable reduction of 99% in the number of
viable bacteria, while nanoHA with green PEE at same
concentrations showed a reduction of 45 and 61%. Moreover,
the nanoHA impregnated with the highest concentration of
red PEE was able to inhibit 80% of the staphylococcal biofilm
formation [136].
Diverse studies show that as the composition of propolis
varies from region to region, the antibacterial activity also
displays some variations [59]. Susceptibility of different
Gram-positive bacteria to PEE varies with the place of
propolis collection [137]. The antibacterial effect was shown
to be higher for samples from a wet-tropical rain forest-
type climate. Other studies revealed the influence of propolis
geographical origin on its antibacterial properties [57, 58, 138,
139]. Propolis from the north and centre of Portugal has a
great activity against S. aureus [58, 140].
4.5.2. Antifungal Activity. Antifungal activity is also influ-
enced by the chemical variation of propolis [59]. Several
studies have shown the effect of propolis from different
geographic origin against different fungi, particularly of
clinical interest [141–145]. Quiroga et al. [146] demonstrated
the antifungal activity of propolis from the northwest of
Argentina, focusing their study on the environment and
the development of agrochemicals with reduced economic
costs, possibly containing propolis extracts and its isolated
compounds, such as pinocembrin and galangin, as active
principles.
Recently, Falca˜o et al. [140] screened the antifungal
activity of Portuguese propolis and its potential floral sources
Populus x Canadensis and Cistus ladanifer against Candida
albicans, Trichophyton rubrum, and Aspergillus fumigatus.
Plant extracts did not exhibit relevant antifungal activity, with
exception of T. rubrum, but both propolis samples revealed
similar antifungal activity, the highest being obtained against
T. rubrum and the lowest against A. fumigatus. A sample of
PEE from Poland showed a high fungicidal activity against
C. albicans, C. glabrata, and C. krusei [147]. Recently, it was
shown that different organic extracts of French propolis (PEE,
PWE,methanolic extract, and dichloromethane extract) were
effective against C. albicans and C. glabrata but only have a
weak activity towards A. fumigates [133].
Brazilian PEE was proved to be active against several
Candida strains (C. albicans, C. tropicalis, C. krusei, and
C. guilliermondii), C. albicans being the most sensitive and
C. guilliermondii the most resistant [141]. Brazilian green
and red propolis display activity against different fungal
species of Trichophyton, which cause dermatophytosis, red
PEE being more efficient than the green one [143]. Also, it
was shown that n-hexane extract of Brazilian red propolis
did not induce resistance in Candida spp. In fact it was
active against Candida spp. resistant to antifungal agents,
like fluconazole [148]. Dota et al. [144] evaluated the in vitro
antifungal activity of PEE and propolis microparticles (PMs)
obtained from a sample from Argentina against clinical yeast
isolates of importance in the vulvovaginal candidiasis. C.
albicans and non-C. albicanswere inhibited by PEE and PMs,
with small variation. Additionally, it was shown that Brazilian
green PEE has the ability to inhibit growth and biofilm
formation by C. albicans from vulvovaginal candidiasis [149].
Another study showed fungicide action of propolis (PEE,
PWE, propolis matricial microparticles (PMM), and propolis
soluble dry extract after 6–8-hour treatment against all three
Evidence-Based Complementary and Alternative Medicine 17
C. albicansmorphotypes (yeast, pseudohyphae, and hyphae),
PEE being the most potent followed by PSDE, PM, and
PWE [150]. Brazilian propolis induces C. albicans cell death
mediated via metacaspase, since the metacaspase mutant in
C. albicans showed reduced sensitivity to propolis, and by
the Ras pathway. Using C. albicans deletion libraries, it was
possible to screen several mutants in genes involved either
in the morphological transitions or in the maintenance of a
specific morphotype that are more sensitive to propolis. To
conclude the study, the authors also showed that propolis
based gels and cream were partially able to control vulvo-
vaginal candidiasis in a mouse model [151]. These studies
[144] strongly indicate that propolis has a great potential to
control vulvovaginal candidiasis, representing a promising
alternative therapeutic strategy.
4.6. Antitumour Activity. Recognition of the hallmarks of
cancer affects the search and development of new meth-
ods and therapeutic agents with a sufficiently large thera-
peutic window to kill tumour cells while sparing normal
cells. In the last years, the natural product propolis has
attracted a growing interest by a large number of researchers
since it contains a variety of phytochemical compounds
that may act through multiple pathways to reduce the
development and other malignant characteristics of cancer
cells.
Recently, several in vitro studies have demonstrated a
cytotoxic action of propolis from different geographic origin
and of some of its isolated compounds on various tumour
cells. In vivo studies also show a potential in the development
of new antitumor agents, since propolis administration to
mammals (e.g., rats) does not lead to detectable side effects
[3]. Briefly, this natural product can block specific oncogene
signalling pathways, which in turn lead to a decrease in cell
proliferation and growth and can also act by decreasing the
cancer stem cell population, increasing apoptosis, exerting
antiangiogenic effects, and modulating the tumour microen-
vironment [66, 152, 153]. Table 8 summarizes the antitumour
activity of propolis from different geographic origin and its
chemical constituents.
Some researchers showed the effect of different types of
propolis and its constituents on cancer cell growth, prolifera-
tion, and apoptosis.The hexane extract of propolis fromThai-
land, collected by the stingless bee Trigona laeviceps, which
has a different behavior in propolis collection compared to
the honey bees, exerts antiproliferative activity against five
tested cancer cell lines (Chago, KATO-III, SW620, BT474,
and Hep-G2) but not against the normal cell lines tested
(HS27 fibroblast and CH-liver) [5]. A sample of PEE from
Poland inhibited human malignant melanoma (Me45) and
colorectal cancer (HCT 116) cells growth, as well as reduced
cell size [154].Other studies reported the antitumor activity of
BrazilianPEE [155–158]which regulate the protein expression
of cyclin D1, B1 and cyclin dependent kinase (CDK) as well
as p21 in human prostate cancer cells, significantly affecting
proliferation [158].
Although propolis containing CAPE is different from
those with artepillin C, it is possible to obtain a similar
inhibitory effect from both types. The effect of CAPE on
different cancer cell lines was analysed and many of its
effects have been shown to be mediated through inhibition
of NF-𝜅B [66, 159]. CAPE can inhibit the proliferation of the
colorectal cell line SW480 by decreasing the 𝛽-catenin, c-
myc, and cyclin D1 protein expression [160]. Chuu et al. [161]
observed that CAPE suppressed the proliferation of LNCaP,
DU-145, and PC-3 human prostate cancer cells in a dose-
dependent manner and also inhibited the tumour growth
of LNCaP xenografts in nude mice. It was suggested that it
acted through inhibition of p70S6K (an intermediary of the
PI3K/AKTpathway responsible for the protein synthesis) and
some Akt signalling networks. Wu et al. [162] demonstrated
that CAPE inhibits in vitro and in vivoMCF-7 andMDA-MB-
231 tumour growthwithoutmuch effect on normalmammary
cells by reducing the expression of growth and transcription
factors, including NF-𝜅B. Recently, it was demonstrated that
CAPE effect on genes that are associated with tumour cell
growth and survival is related in part to its role as a histone
deacetylase inhibitor [163].
As previously said, propolis can also act by decreasing
the cancer stem cell population. Using the putative CD44
(+)/CD24 (−/low) breast cancer stem cells able to generate
mammospheres from single cells, Omene et al. [164] showed
that CAPE caused a dose-dependent inhibition of cancer
stem cells self-renewal, progenitor formation, and clonal
growth.
Concerning cell death, some in vitro studies showed
different sensitivities of tumour cells to propolis extracts.
PWE from Iraq inhibits the proliferation of HL-60 cells
and leads to downregulation of Bcl-2 and activation of Bax
[13]. Alizadeh et al. [165] investigated the protective effects
of Iranian PEE on N-methyl-N-nitro-N-nitrosoguanidine-
(MNNG-) initiated gastric cancer in rats. Results showed
that tumour incidence, the number of lesions, structural
abnormalities, and beta-catenin of the animals group treated
with PEE significantly declined compared with the control.
PEE also induced the expression of proapoptotic Bax and
reduced antiapoptotic Bcl-2 expression. Propolis inhibits
colony formation potential and promotes necrotic changes in
HCT-116 cells and decreases mitotic cells and increases p53
and Ki-67 expression in HCT-116 tumor-bearing mice [13].
Szliszka’s group have performed many studies to analyze the
antitumour effect of different propolis and its constituents
on prostate cancer cells (LNCaP and DU145) [166–168].
Brazilian green PEE sensitized these cells to TRAIL-induced
death, enhanced the expression of TRAIL-R2, and decreased
the activity of NF-𝜅B in LNCaP cells [167]. Cotreatment of
TRAIL with artepillin C induced the significant activation of
caspase-8 and caspase-3, as well as a significant disruption of
the mitochondrial membrane potential [169]. Many studies
have been conducted to understand the pathways involved
in the apoptotic effect of CAPE. CAPE induces cell cycle
arrest and apoptosis and reduces expression of NF-𝜅B in
MDA-MB-231 and MCF-7 human breast cancer cells [162].
In PC3 prostate cancer cells, CAPE induced apoptosis in a
dose-dependent manner that was associated with the loss of
expression of the inhibitors of apoptosis: cIAP-1, cIAP-2, and
XIAP [170]. Cavaliere et al. [171] showed that CAPE treatment
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of lymphoblastoid cell line PL104 induced apoptosis through
the mitochondrial intrinsic pathway.
It has been known that cancer microenvironment is
very important for carcinogenesis and it consists of stromal,
endothelial, immune, and cancer cells. Natural products,
like propolis and their constituents, have been shown to
interfere with this symbiosis. It was demonstrated by Lee et al.
[172] that CAPE could effectively suppress the adhesion and
invasion potential of human hepatocellular carcinoma cells
(SK-Hep1) by inhibiting the expression ofMMP-2 andMMP-
9 and NF-𝜅B.
Angiogenesis has a crucial role in tumour growth due
to the requirement of oxygen and nutrients to sustain rapid
uncontrolled proliferation and metastization. Both tumour
and stromal cells can secrete proangiogenic factors that
stimulate the formation andmaintenance of new vessels, such
as vascular endothelial growth factor (VEGF) [173]. Brazilian
PEE could significantly reduce the number of newly formed
vessels and suppress the proliferation of human umbilical
vein endothelial cells (HUVECs) [174], this antiangiogenic
effect being mainly mediated via inducing apoptosis in tube-
forming endothelial cells through the inactivation of the sur-
vival signal ERK1/2 [175]. Yun et al. [176] observed that CAPE
inhibited angiogenesis using the in vivo assay chick embryo
chorioallantoic membrane (CAM). CAPE also suppresses
VEGF formation by MDA-MB-231 cells and formation of
capillary-like tubes by endothelial cells [162, 177]. Extracts
of propolis containing artepillin C and CAPE significantly
reduced the newly formed vessels and expression of MMPs
and VEGF production from various cells [178] and, in
accordance with this study, Izuta et al. [179] described that
CAPE promotes inhibition of VEGF expression in HUVEC
cells.
The first study on the antitumor activity of Portuguese
propolis was only performed in 2010. Using normal and
cancerous renal cells derived from human renal cell carci-
noma (RCC) patients, in addition to A-498 cell line, Valente
et al. [64] showed that methanolic extract of Portuguese
propolis exhibited selective toxicity against malignant cells
compared to normal cells and in vitro RCC growth was
strongly inhibited. Recently, our group demonstrated the
antitumour and antiangiogenic activity of the ethanol extract
of Pereiro propolis (P10.EE), collected in the district of
Guarda, Portugal. P10.EE affects cell viability of different
tumour cells, MDA-MB-231 (breast) and DU145 (prostate)
being two of the most sensitive ones, but was less cytotoxic
against nontumour cells and fibroblasts. Also, it signifi-
cantly decreased MDA-MB-231 and DU145 cell prolifera-
tion and migration along time, with cell cycle changes,
and increased cell death. The significant increase observed
in glucose consumption and lactate production could be
explained in MDA-MB-231 by an increased expression of
hypoxia inducible factor-1𝛼, pyruvate dehydrogenase kinase,
glucose transporter 1, lactate dehydrogenase, and carbonic
anhydrase. Furthermore, P10.EE induced a decrease in
HBMECs total biomass and proliferation and decreased
vessel sprouting in the chicken chorioallantoic membrane
[23].
5. Conclusions
From ancient to modern times, herbs and other plant prod-
ucts have been widely used as medicinal agents, first in folk
medicine and other activities in many parts of the world and
later developed and improved on a scientific basis into drugs
that are used in the health system. Propolis is one of the
few natural products that has maintained its popularity over
a long period of time. As reviewed here, propolis contains
a broad spectrum of compounds that may be useful in the
treatment of different pathological conditions. In fact there is
much literature that deals with the in vitro and in vivo biologi-
cal properties of propolis.This wide range of bioactivities, the
continuous discovery of new compounds, the long history of
propolis use, and its safety profile make propolis a potential
candidate for drug discovery that may be useful in several
clinical scenarios. Nevertheless, it is necessary to make an
effort to standardize propolis composition since it seems that
propolis biological properties and chemical composition not
only are variable but also are strictly linked. In our opinion,
propolis extracts may be important economically and would
allow a relatively inexpensive treatment in different diseases;
however, to promote its use in modern medicine, it will be
necessary to identify and isolate the bioactive compounds
to be tested separately or in combination with other drugs
already available.
Drug discovery does not consist only of the isolation
of bioactive lead compounds from the natural sources. In
fact, this process continues outside the academic laboratories
through preclinical studies followed by clinical trials. Thus,
despite the in vitro and in vivo assays, which provide new
valuable information on propolis biological properties and
mechanisms of action, it will be necessary to analyse the
effectiveness of propolis clinically, to complement the basic
research available, and to evaluate the potential of propolis in
human health promotion.
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